Published in Daru on January 05, 2013
The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress. PLoS One (2015) 0.77
Large-scale microfluidics providing high-resolution and high-throughput screening of Caenorhabditis elegans poly-glutamine aggregation model. Nat Commun (2016) 0.75
The antidepressant-like activity of AC-5216, a ligand for 18KDa translocator protein (TSPO), in an animal model of diabetes mellitus. Sci Rep (2016) 0.75
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83
Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl (1996) 3.99
Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study. J Clin Psychiatry (2006) 1.67
Amitriptyline, weight gain and carbohydrate craving: a side effect. Br J Psychiatry (1973) 1.56
Weight gain and antidepressants. J Clin Psychiatry (2000) 1.49
Clinical pharmacokinetics of fluoxetine. Clin Pharmacokinet (1994) 1.45
Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev (2005) 1.41
Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. J Clin Psychiatry (2000) 1.36
Changes in weight during a 1-year trial of fluoxetine. Am J Psychiatry (1999) 1.26
Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells. Neurosci Lett (2005) 1.05
Weight gain. A side-effect of tricyclic antidepressants. J Affect Disord (1984) 1.00
Weight gain with antidepressants and lithium. J Clin Psychopharmacol (1988) 0.98
The effect of the 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects. Int J Obes (1990) 0.93
The effect of antidepressants on lipid homeostasis: a cardiac safety concern? Expert Opin Drug Saf (2006) 0.91
Fluoxetine-induced reduction of body mass in patients with major depressive disorder. Psychopharmacol Bull (1988) 0.82
Imipramine and weight gain during the treatment of recurrent depression. J Affect Disord (1990) 0.80
Chronic imipramine treatment and weight gain. Psychiatry Res (1986) 0.79
[Weight gain during antidepressant therapy]. Psychiatr Pol (1993) 0.79
Doxepin increases serum cholesterol levels. Can J Psychiatry (2004) 0.79
Metabolic and physiologic consequences of nortriptyline treatment in the elderly. Psychopharmacol Bull (1994) 0.78
Effect of prolonged trifluoperazine, imipramine and haloperidol administration on serum cholesterol. An experimental study in rabbits. Pharmacology (1976) 0.78
Cytotoxic activity of some marine brown algae against cancer cell lines. Biol Res (2010) 1.16
Epidemiology of major depressive disorder in iran: a systematic review and meta-analysis. Int J Prev Med (2010) 1.08
Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord (2010) 1.00
Effects of cigarette smoking on priapism induced by quetiapine: a case report. Daru (2012) 0.92
Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study. Hum Psychopharmacol (2012) 0.90
Opioid detoxification using high doses of buprenorphine in 24 hours: a randomized, double blind, controlled clinical trial. J Subst Abuse Treat (2004) 0.90
A tailored educational intervention improves doctor's performance in managing depression: a randomized controlled trial. J Eval Clin Pract (2011) 0.86
Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder. J Clin Psychopharmacol (2004) 0.85
Training and validation of standardized patients for unannounced assessment of physicians' management of depression. Acad Psychiatry (2011) 0.84
Applying a modified Prochaska's model of readiness to change for general practitioners on depressive disorders in CME programmes: validation of tool. J Eval Clin Pract (2007) 0.83
Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial. Int Immunopharmacol (2013) 0.82
Risk factors of thyroid abnormalities in bipolar patients receiving lithium: a case control study. BMC Psychiatry (2003) 0.80
Effects on knowledge and attitudes of using stages of change to train general practitioners on management of depression: a randomized controlled study. Can J Psychiatry (2009) 0.79
Assessment of Defense Styles and Mechanisms in Iranian Patients Suffering from Obsessive Compulsive or Panic Disorders versus Normal Controls using Persian Version of Defense Style Questionnaire-40. Iran J Psychiatry (2012) 0.79
Cyproheptadine for prevention of neuropsychiatric adverse effects of efavirenz: a randomized clinical trial. AIDS Patient Care STDS (2013) 0.79
Comparing effects of clonazepam and zolpidem on sleep quality of patients on maintenance hemodialysis. Iran J Kidney Dis (2011) 0.79
Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz. Expert Opin Pharmacother (2012) 0.78
Effects of risperidone on lipid profile. Ann Pharmacother (2007) 0.77
Memantine-induced speech problems in two patients with autistic disorder. Daru (2013) 0.76
Topiramate versus Valproate Sodium as Adjunctive Therapies to a Combination of Lithium and Risperidone for Adolescents with Bipolar I Disorder: Effects on Weight and Serum Lipid Profiles. Iran J Psychiatry (2012) 0.75
Trifluoperazine-induced cholestatic jaundice. Iran J Psychiatry (2010) 0.75
Undiagnosed Bipolar Disorders in Patients with Major Depressive Episode: Iran's part of a Multicenter Cross-Sectional Study. Iran J Psychiatry (2013) 0.75
Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study. Swiss Med Wkly (2014) 0.75
Comparing the effects of high-dose vitamin E with those of placebo on insulin resistance in patients with schizophrenia treated with olanzapine. J Clin Psychopharmacol (2009) 0.75
Analysis of the antiepileptic, ethosuximide impacts on neurogenesis of rat forebrain stem cells. Fundam Clin Pharmacol (2014) 0.75